1. Home
  2. IMRN vs HWH Comparison

IMRN vs HWH Comparison

Compare IMRN & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • HWH
  • Stock Information
  • Founded
  • IMRN 1994
  • HWH 2021
  • Country
  • IMRN Australia
  • HWH United States
  • Employees
  • IMRN N/A
  • HWH N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • HWH Other Pharmaceuticals
  • Sector
  • IMRN Health Care
  • HWH Health Care
  • Exchange
  • IMRN Nasdaq
  • HWH Nasdaq
  • Market Cap
  • IMRN 9.2M
  • HWH 10.1M
  • IPO Year
  • IMRN N/A
  • HWH N/A
  • Fundamental
  • Price
  • IMRN $1.86
  • HWH $5.13
  • Analyst Decision
  • IMRN Strong Buy
  • HWH
  • Analyst Count
  • IMRN 1
  • HWH 0
  • Target Price
  • IMRN $5.00
  • HWH N/A
  • AVG Volume (30 Days)
  • IMRN 55.1K
  • HWH 19.1M
  • Earning Date
  • IMRN 08-29-2025
  • HWH 08-14-2025
  • Dividend Yield
  • IMRN N/A
  • HWH N/A
  • EPS Growth
  • IMRN N/A
  • HWH N/A
  • EPS
  • IMRN N/A
  • HWH N/A
  • Revenue
  • IMRN $4,777,422.00
  • HWH $1,238,173.00
  • Revenue This Year
  • IMRN N/A
  • HWH N/A
  • Revenue Next Year
  • IMRN N/A
  • HWH N/A
  • P/E Ratio
  • IMRN N/A
  • HWH N/A
  • Revenue Growth
  • IMRN 48.63
  • HWH 17.28
  • 52 Week Low
  • IMRN $1.50
  • HWH $0.90
  • 52 Week High
  • IMRN $2.87
  • HWH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.87
  • HWH 73.71
  • Support Level
  • IMRN $1.73
  • HWH $1.38
  • Resistance Level
  • IMRN $1.89
  • HWH $7.16
  • Average True Range (ATR)
  • IMRN 0.10
  • HWH 0.83
  • MACD
  • IMRN 0.01
  • HWH 0.47
  • Stochastic Oscillator
  • IMRN 76.77
  • HWH 59.07

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About HWH HWH International Inc.

HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.

Share on Social Networks: